WOCKPHARMA - Swing Trade Analysis with AI Signals

Last Updated Time : 19 Sept 25, 2:15 pm

Swing Trade Rating: 3.4

💊 WOCKPHARMA Swing Trade Analysis

WOCKPHARMA (Wockhardt Ltd.) presents a speculative swing trade setup. While recent earnings have surged and institutional sentiment is mildly positive, weak fundamentals and bearish technical indicators suggest caution.

✅ Positives

Earnings Momentum

PAT Growth: ₹40 Cr. → ₹69 Cr. — up 1,050%, signaling a sharp turnaround.

EPS: ₹3.01 — improving earnings base.

Institutional Sentiment

FII Holding Up: +0.47%

DII Holding Up: +0.42%

Price Above 200 DMA (₹1,419) — long-term trend support.

⚠️ Negatives

Valuation Concerns

P/E: 486 vs Industry PE: 33.4 — extremely overvalued.

PEG Ratio: 20.1 — growth doesn’t justify valuation.

Weak Fundamentals

ROCE: 4.40% / ROE: -0.53% — poor capital efficiency.

Dividend Yield: 0.00% — no income support.

Debt-to-Equity: 0.65 — moderately high leverage.

Technical Weakness

MACD: -2.04 — bearish crossover, signaling downward momentum.

RSI: 51.4 — neutral zone, lacking strength.

Volume Drop: Current volume is ~17% below 1-week average.

Price Below 50 DMA (₹1,537) — short-term trend remains weak.

52W Index: 64.0% — mid-range, indicating partial recovery.

🎯 Trade Strategy

Optimal Entry Price: ₹1,500–₹1,510

Enter only if MACD flattens and RSI trends upward.

Exit Plan (If Holding)

Target Exit: ₹1,580–₹1,600

Conservative target near short-term resistance.

Stop Loss: ₹1,470

Below recent support to manage downside risk.

WOCKPHARMA is a speculative swing candidate best suited for traders who can monitor technical reversals and manage valuation risk. Let me know if you'd like to compare it with other pharma turnaround plays.

Edit in a page